HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?

PURPOSE OF REVIEW: This review aims to summarize and discuss the recent findings in the field of using HDL mimetics for the treatment of patients with coronary artery disease. RECENT FINDINGS: Following the largely disappointing results with the cholesteryl ester transfer protein inhibitors, focus m...

Descripción completa

Detalles Bibliográficos
Autores principales: Karalis, I., Jukema, J. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010501/
https://www.ncbi.nlm.nih.gov/pubmed/29926215
http://dx.doi.org/10.1007/s11886-018-1004-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010501/
https://www.ncbi.nlm.nih.gov/pubmed/29926215
http://dx.doi.org/10.1007/s11886-018-1004-9

Ejemplares similares